Swk Holdings Corp. logo

Swk Holdings Corp. (SWKH)

Market Closed
6 Apr, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
15. 90
0
0%
$
192.33M Market Cap
13.8 P/E Ratio
- Div Yield
105,554 Volume
1.85 Eps
$ 15.9
Previous Close
Analysts:
Add Transaction
Day Range
15.9 15.9
Year Range
12.54 17.9
Want to track SWKH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

SWKH closed Monday higher at $15.9, an increase of 0% from Friday's close, completing a monthly decrease of -4.7904% or -$0.8. Over the past 12 months, SWKH stock lost -6.6901%.
SWKH is not paying dividends to its shareholders.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.1139%, based on the last three reports.
Swk Holdings Corp. has completed 4 stock splits, with the recent split occurring on Apr 24, 2025.
The company's stock is traded on one exchange.

SWKH Chart

Stanley Black & Decker (SWK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Stanley Black & Decker (SWK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Stanley Black & Decker (SWK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 13 hours ago
Here's Why Stanley Black & Decker (SWK) is a Strong Value Stock

Here's Why Stanley Black & Decker (SWK) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 6 days ago
Here's Why Stanley Black & Decker (SWK) is a Strong Momentum Stock

Here's Why Stanley Black & Decker (SWK) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 week ago

Swk Holdings Corp. Investors

Name Quantity Cost Value Profit ($) Gain (%)
CE
Curtis Ellergodt Rothschild Investment LLC
7 $107.29 $111.3 $4.01 3.74%
SN
Stephanie Nee HARBOR CAPITAL ADVISORS Inc.
336 $4,580.13 $5,342.4 $762.27 16.64%
Ana-Maria Ignat
Ana-Maria Ignat Covestor Ltd
32 $465.6 $508.8 $43.2 9.28%
Alexandra Stickelman
Alexandra Stickelman Root Financial Partners, LLC
1 $17 $15.9 -$1.1 -6.47%
Mark Schafer
Mark Schafer Police & Firemen's Retirement System of New Jersey
1,369 $20,179 $21,767.1 $1,588.1 7.87%

Swk Holdings Corp. Analysts

Name Quantity Cost Value Profit ($) Gain (%)
MD
Michael Diana Maxim Group
- - - - -

Swk Holdings Corp. (SWKH) FAQ

What is the stock price today?

The current price is $15.90.

On which exchange is it traded?

Swk Holdings Corp. is listed on NASDAQ (NMS).

What is its stock symbol?

The ticker symbol is SWKH.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 192.33M.

Has Swk Holdings Corp. ever had a stock split?

Swk Holdings Corp. had 4 splits and the recent split was on Apr 24, 2025.

Swk Holdings Corp. Profile

Capital Markets Industry
Financials Sector
Jody. D Staggs CEO
NASDAQ (NMS) Exchange
78501P203 CUSIP
US Country
24 Employees
- Last Dividend
24 Apr 2025 Last Split
22 Sep 1999 IPO Date

Overview

SWK Holdings Corporation, headquartered in Dallas, Texas, is a specialized financial service and asset management firm operating predominantly within the United States. Initially known as Kana Software, Inc., the company underwent a name change to SWK Holdings Corporation in December 2009. Since its inception in 1996, SWK Holdings has distinguished itself by focusing on the life sciences sector, providing a unique blend of financial solutions and services to a diversified client base. The company functions through two main divisions: Finance Receivables and Pharmaceutical Development, catering to a wide array of needs in the life science community, including biotechnology, medical devices, diagnostics, animal health, and pharmaceuticals.

Products and Services

  • Finance Receivables

    This segment of SWK Holdings offers tailored financing solutions targeting a broad spectrum of life science companies and inventors. The clientele encompasses entities from the biotechnology, medical device, diagnostics, animal health, and pharmaceutical industries, among others. By providing flexible financing options, SWK Holdings supports the growth and advancement of companies and technologies within these sectors. Additionally, this segment extends non-discretionary investment advisory services to institutional clients, managing accounts specifically geared towards investments in life science finance.

  • Pharmaceutical Development

    SWK Holdings' Pharmaceutical Development segment delivers wide-ranging services in pharmaceutical development, formulation, and manufacturing. It is notably recognized for the Peptelligence platform, a proprietary oral drug delivery technology that offers innovative formulation solutions. The segment’s capabilities facilitate the development process for clients, from conceptualization to final product creation, encompassing both development services and formulation technologies. Furthermore, SWK Holdings engages in the intellectual property licensing business, leveraging its developments and technologies to establish partnerships and collaborations within the industry.

Contact Information

Address: 14755 Preston Road
Phone: 972 687 7250